1 / 3

Transcriptomics Market

Transcriptomics is the study of the transcriptome which is the entire set of RNA transcripts created by the genome under certain circumstances or in a specific cell, using highly specific scientific methods.

Rachana1
Download Presentation

Transcriptomics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Massive Growth of Transcriptomics Market by 2029 with Top Key Players: Illumina Inc., Eurofins Scientific SE, Merck KgaA, Acobiom The global transcriptomics market peaked at US$ 4.5 billion in 2021. The market is expected to witness a CAGR of 13.50% from 2022 to 2030. RNA sequencing truly has revolutionized transcriptome examination, permitting the quantification of gene expression levels and allele-specific expression in single research, as well as the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. The demand for RNA sequencing in the research field is growing because it uses a highly scientific study to obtain information at the genetic level, although it is highly sensitive to genes that produce output very smoothly when using this technology. Transcriptomics is the study of the transcriptome which is the entire set of RNA transcripts created by the genome under certain circumstances or in a specific cell, using highly specific scientific methods. The market is influenced by factors such as increased research on new chronic diseases, the rise in the application of RNA sequencing, and funding provided by the government in omics. For instance, the Life Sciences Innovative Manufacturing Funds (LSIMF) Which is a part of global Britain Investments Funds, invested 354 million euros, in March 2022. Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request- sample/transcriptomics-market/7733 Key Players Mentioned in the Transcriptomics Market: Bio-Rad Laboratories Inc. Thermo Fisher Scientific Inc. Agilent Technologies Inc. Illumina Inc. Qiagen N.V F. Hoffman La Roche Ltd. Eurofins Scientific SE Fluidigm Corporation Merck KgaA Acobiom CD Genomics By Application: Drug Discovery Clinical Diagnostics Toxicogenomics By Technology: Microarray Polymerase Chain Reaction Sequencing Key Reasons to Purchase:

  2. (1)To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape. (2)Assess the production processes, major issues, and solutions to mitigate the development risk. (3)To understand the most affecting driving and restraining forces in the Transcriptomics Market and its impact in the global market. (4)Learn about the market strategies that are being adopted by leading respective organizations. (5)To understand the outlook and prospects for the market. TOC of Global Transcriptomics Market 1 Scope of the Report 1.1 Market Ecosystem 1.2 Geographic Scope 1.3 Timeline Under Consideration 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Transcriptomics Market Executive Summary 2.1 World Market Overview 2.1.1 Global Market Size 2021-2031 2.1.2 Market Size CAGR by Region 2020 VS 2028 2.2 Transcriptomics Market Segment by Type 2.2.1 Type 1 2.2.2 Type 2 Browse the full report now: https://growthplusreports.com/report/transcriptomics-market/7733 About Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

More Related